SENORX (SENO) Tops Q3 EPS by 13c; Guides Revs
More News related to SENO
- SenoRx (SENO) CEO and Chair Lloyd Malchow to Take Medical Leave
- SenoRx Announces CEO to Take Medical Leave of Absence
- SenoRx Announces Fourth Quarter and Fiscal Year 2009 Conference Call and Webcast
- Small Cap Sentinel: Innovation at the Crossroads of Women's Health and Oncology
- Unusual 11 Mid-Day Movers 12/18: IHR, SENO, SMOD, AIRV Higher; RPTP, PALM, LDK, ZLC Lower
More News related to Earnings
- Wright Express (WXS) Reports Q4 EPS of $0.56, Beats by 2c; Guides Q1, FY10
- Commtouch Software Ltd. (CTCH) Posts Q4 EPS of $0.13, Beats Y/Y; Guides FY10 Revs
- Scripps Networks (SNI) Tops Q4 Views
- Lance, Inc. (LNCE) Posts Q4 EPS of $0.36, Misses Views by 2c; Declares $0.16 Quarterly Dividend; 2.8% Yield
- TransDigm (TDG) Posts Q4 adj.-EPS of $0.70, Misses by 1c; Guides FY10 Below Street
SENORX Inc. (NASDAQ: SENO) reports Q3 EPS of $0.01 loss, 13 cents better than the analyst estimate of ($0.14). Revenue for the quarter was $13.7 million, which compares to the estimate of $14.10. million.
SENORX sees FY revs of $56-$57 million, versus $56.2 million consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
